Pfizer and BioNTech have released data showing a strong immune response in children aged 5 to 11 years old after receiving a booster dose of their COVID-19 vaccine

Excerpt Following a booster (third) dose of the Pfizer-BioNTech COVID-19 Vaccine, data from a subanalysis of 30 sera from a Phase 2/3 clinical study of children aged 5 to 11 years old reveal a 36-fold rise in SARS-CoV-2 Omicron neutralising titers. A booster (third) dose of the Pfizer-BioNTech COVID-19 Vaccine enhanced neutralising antibodies against the […]

Singapore and Asia’s leading BioPharma Map the Future and Catalyze Recovery for the Biomanufacturing Industry

Singapore, 31st March 2022 – The 9th Annual Biologics Manufacturing Asia 2022 & the 6th Annual BioLogistics World Asia 2022 conferences kicks off with Industry views on post pandemic biomanufacturing and a focus on the future of Asia’s Bioprocessing sector. The annual event gathered biologics and vaccine experts from all over the world at Suntec […]

Biovac and Development Partners Collaborate to Help South Africa Expand Its Vaccine Manufacturing Capacity and Advance Africa’s Long-Term Health Security

Excerpt Consortium of nine development partners to support Biovac’s expansion of its existing vaccine manufacturing plant capacity, and enable the production of Pfizer-BioNTech’s COVID-19 vaccine and other vaccines. Biovac plans to raise about $150 million (ZAR2.3 billion) to expand indigenous vaccine manufacturing capacity across Africa. Partners include AfDB, CDC Group, DEG, DFC, EIB, IFC, Proparco, […]

Nipah Survivors Study to Advance New Vaccines Against Highly Fatal Threat

Excerpt CEPI will expand its collaboration with icddr,b in Bangladesh, offering nearly $1 million in financing to help researchers better understand the Nipah virus. The Nipah virus is still one of the most lethal illnesses known to humans, but no vaccinations are currently approved for use. The research will also aid in the development of […]

Serum Institute of India and GreenLight Biosciences Multitarget Licensing Agreement

Excerpt GreenLight has been engaged by the Serum Institute of India to develop three messenger RNA products, including a shingles vaccine. The Serum Institute of India also has the option of expanding the partnership to include two more vaccine or therapeutic targets. The Serum Institute of India will be granted a license to develop, manufacture, […]

Sanofi to Invest $1 Bn in Developing mRNA Vaccines in France

Excerpt Sanofi announced on Monday a 935 million euro investment plan from 2022 to 2026 to offer France a complete and autonomous value chain in mRNA technology, from R&D to production, as part of its €2 billion plan to accelerate its mRNA strategy launched in July 2021. This announcement was made in the presence of […]

Afrigen Biologics Becomes the First African Company to Make an mRNA Vaccine on the Continent

Excerpt Scientists from a local biotechnology business Afrigen Biologics, in South Africa have made history by developing and manufacturing an mRNA COVID-19 vaccine using publicly available Moderna data, marking the first time in Africa that an mRNA vaccine has been created and manufactured at a laboratory scale.  Article Summary Scientists from a local biotechnology business […]

Dr. Reddy’s Laboratories Receives Approval from the DCGI for the Single-Shot Sputnik Light Vaccine in India

Excerpt Dr. Reddy’s Laboratories has received DCGI approval for the single-shot Sputnik Light vaccine in India. Sputnik Light is the latest vaccine to be approved in India as part of the national inoculation effort to combat COVID-19. Sputnik Light is Dr. Reddy’s Laboratories’ second COVID-19 vaccine to be made available in India. Article Summary The […]

Curevo Vaccine Raises $60 Million in Series A Financing to Assist in the Clinical Development of Next-Generation Subunit Vaccines

Excerpt Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology business dedicated to producing safe and highly effective vaccines to reduce the burden of infectious disease, announced the completion of a $60 million Series A fundraising transaction. This round provides Curevo with funding through topline data from the 678-patient Phase 2b trial of CRV-101, their vaccine […]

With Strong Assistance from African and European Partners, WHO Announces the First Technology Recipients of the mRNA Vaccine Hub

Excerpt At the European Union – African Union summit in Brussels, the WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, announced the first six countries that will receive the technology needed to produce mRNA vaccines on the African continent. Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia all applied and have been selected as recipients. Article Summary […]

The Bill and Melinda Gates Foundation and Wellcome have pledged $300 million to CEPI to address COVID-19 and future pandemic threats

Excerpt The Bill and Melinda Gates Foundation and Wellcome have pledged $300 million to CEPI to address COVID-19 and future pandemic threats. CEPI’s goal of reducing new vaccine development timeframes to 100 days, a third of the time it took to develop a COVID-19 vaccine, will be aided by fresh funding pledges. Pledges help CEPI […]

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine

Excerpt BioNTech and Pfizer today announced a new research, development, and commercialization partnership to develop the first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring, and painful disease that affects one in every three people in the United States at some point in their lives. Article Summary BioNTech […]